Teva collaboration agreement aims to accelerate clinical data generation for TEV-56278 and develop Anti-PD1-IL2 Therapy.

Looking at key trends in outsourcing, manufacturing, and regulatory compliance. Embracing innovation, flexibility, and talent ...